Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
-
* Corresponding author: Jeffrey P Gregg jpgregg@ucdavis.edu
Breast Cancer Research 2005, 7:R881-R889 doi:10.1186/bcr1317
No comments have yet been made on this article.